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Abstract
Perimenopausal disorders (PDs) are prevalent and importantly affect quality of life among
middle-aged women. Yet, very little is known about the developmental origins of these
disorders. The objective of this study was to investigate the associations of birth
characteristics with PDs. This cohort study is based on archived birth records for birth
weight and gestational age, and followed prospectively in Swedish inpatient and outpatient
registers for 8 years (n= 3212). The main outcomes were menopausal and climacteric states
(e.g. flushing, sleeplessness), perimenopausal bleeding and other PDs (e.g. atrophic vaginitis).
Cox proportional hazards regression models were used to estimate the hazard ratios (HRs) for
three subtypes of PDs separately. During the follow-up, 218 women had PDs, among whom
125 had menopausal and climacteric states, 61 had perimenopausal bleeding and 58 had other
PDs as first recorded disorder. Birth weight was linearly associated with incidence rate of
menopausal and climacteric states [HR= 1.66 per 1 kg increase, 95% confidence interval
(95% CI)= 1.14–2.41]. Gestational age (rather than birth weight) was associated with
incidence rate of other PDs (HR= 0.87 per 1 week increase, 95% CI= 0.79–0.95). Neither
birth weight nor gestational age was associated with perimenopausal bleeding. Similar results
were found after adjustment for other early-life and adult socio-demographic characteristics.
This observational study provides, for the first time, evidence regarding the developmental
origins of PDs. Future research is required to investigate the underlying causal mechanisms,
which may shed further light on the etiology of this class of disorders.
Introduction
Perimenopausal disorders (PDs) result from variations in reproductive hormones levels or
from gynecological lesions occurring during and after the menopausal transition period.1–3
They typically present with a range of vasomotor, psychological, somatic and vaginal
symptoms.1,4,5 The International Classification of Diseases categorizes PDs into three main
subtypes: menopausal and climacteric states (e.g. flushing, sleeplessness, headaches and poor
concentration); perimenopausal bleeding (i.e. abnormal vaginal bleeding in peri- and
postmenopausal period) and other PDs (e.g. atrophic vaginitis, atrophy of cervix or endo-
metrium and other unspecified disorders). It is estimated that around 80% of post-
menopausal women experience at least one symptom,6 which can be bothersome that drives
10% of women to seek health care and potentially get a clinical diagnosed disorder.6 These
highly prevalent symptoms, and the corresponding disorders, can have a substantial negative
impact on women’s general health and quality of life, with related costs to families, the
health care system and society.7,8 Understanding the etiology of clinical diagnosed disorders,
including their potential developmental origins, is one important step towards reducing the
health burden.
In the past 30 years, it has become clear that characteristics such as birth weight and
gestational age are not only key outcomes of infant health in their own right but also predict
subsequent health and disease risks. For instance, low birth weight is associated with higher
risks of coronary heart disease,9 low adult bone mass10 and all-cause mortality,11 whereas
higher birth weight is associated with adult obesity13 and some site-specific cancers.12,13 Such
findings support the hypothesis of the developmental origins of health and disease, which
highlights the developmental plasticity of the human body,14 and the consequent ways in
which the prenatal environment exerts long-term influences on the development of meta-
bolism and organ functions.15–17
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It has been previously proposed that there may be develop-
mental origins for ovarian ageing, according to reported asso-
ciations between higher birth weight or extremes of birth weight
and earlier menopause.18,19 Therefore, birth characteristics may
plausibly also be linked to other menopause-related health mar-
kers such as symptoms during the perimenopausal period, but to
our knowledge no earlier study has examined this. Instead, pre-
viously identified risk factors for perimenopausal symptoms are
mainly restricted to those operating in early adulthood or during
the menopausal transition period, such as lifestyle factors, life
events and menopausal status.20–22 This lacking attention to
potential early-life predictors likely reflects the fact that most
studies rely on self-reported survey data in which information on
early-life characteristics were poorly recorded, and few existing
data resources enable following women prospectively from birth
to menopause.
The current study addresses this research gap by using a well-
established cohort, examining the developmental origins of three
subtypes of diagnosed PDs recorded in the Swedish national
patient registers, namely menopausal and climacteric states,
perimenopausal bleeding and other PDs (e.g. atrophic vaginitis).
Methods
Study population
This study uses the Uppsala Birth Cohort Multigenerational
Study (UBCoS Multigen). UBCoS Multigen is based on a well-
defined original cohort of 14,192 live births in Uppsala University
Hospital from 1915 to 1929.23 For those cohort members still
living in Uppsala as adults, we identified their offspring through
the Multi-Generation Register and traced their birth data in
archived obstetric records. Such identification and the linkage
with other national registers can be done using the unique per-
sonal identification number in Sweden that each individual is
assigned and remains unchanged throughout the lifetime. The
starting point for the present analysis was the 4290 singleton
female offspring who were born between 1936 and 1968, and were
therefore aged 40–65 years during the follow-up period in 2001–
2008. Then we excluded 258 females who died or emigrated
before the start of follow-up, and a further 820 whose birth
records could not be traced. The final study sample consisted of
3212 women. There was no evidence that the incidence of any of
the three PDs subtypes differed significantly between women with
traceable birth records and those without (all P> 0.10).
Measures
The outcomes are based on clinical diagnosis of PDs identified in
either inpatient or outpatient registers using the International
Classification of Diseases, 10th Revision (ICD-10). The inpatient
register includes public and private inpatient care in Sweden and
reached complete nationwide coverage by 1987, while the out-
patient register is available from 2001.24 Diagnoses classified were
menopausal and climacteric states (code N95.1), perimenopausal
bleeding (codes N92.4 and N95.0) and other PDs (codes N95.2,
N95.8 and N95.9). These outcomes were studied separately due to
potential differences in their etiology. In separate analyses for
each subtype of PDs, we did not censor women who were diag-
nosed with a different subtype of PDs. Incidence of each subtype
of PDs was identified as the first recorded diagnosis for the
specific disorder during the follow-up period. Both main and
contributory diagnoses were considered: the PD was listed as the
main diagnosis in 87% of diagnoses (n= 111) of menopausal and
climacteric states, 91% of diagnoses (n= 58) of perimenopausal
bleeding and 71% of diagnoses (n= 44) of other PDs. Among
other PDs, the most common diagnosis was atrophic vaginitis
[n= 49 (79%)]. States associated with artificial menopause (ICD
code N95.3) were not included among the studied outcomes.
Information on the primary exposure variables, birth weight in
kilogram (kg) and gestational age were obtained from archived
birth records. Gestational age was based on completed weeks
from the last menstrual period of the mother. As an alternative
exposure variable, ponderal index at birth was created as an
indicator of the weight-for-length at birth [calculated as weight
(kg)/birth length3 (meters)]. Ponderal index measures the body
mass of the infant and has been widely used in developmental
origins studies.14
Other early-life characteristics were included as potential
confounding factors. Mother’s age, marital status (married or
unmarried) and parity (1, 2, 3–9) at the birth of the index women
(i.e. study population) were extracted from the archived birth
records. Parental education was measured as the highest lifetime
education of either parent from Census 1960, 1970 and 1990 or
from the longitudinal database on education, income and
employment and longitudinal integration database for health
insurance and labor market studies (LISA) from 1985 onwards.
We combined educational levels into four categories: elementary
(elementary education <10 years), shorter secondary (senior high
education <3 years), longer secondary (senior high 3 + years) and
tertiary education.
Three adult characteristics of the index women were used to
explore the social patterning of PDs and the role of socio-
demographic factors in the associations between birth char-
acteristics and the incidence of PDs. The woman’s lifetime
number of live births was extracted from the Multi-Generation
Register, and the woman’s own education and family disposable
income (in fourths) in the year 2000 were obtained from the LISA
register.
Statistical analysis
Cox proportional hazards regression models were used to esti-
mate hazard ratios (HRs) and 95% confidence intervals (95%
CIs), with age used as the underlying timescale. Study subjects
were followed from January 1, 2001 or their 40th birthday,
whichever came later. Follow-up continued until December 31,
2008, their 65th birthday, death, emigration or the first diagnosis
of the disorder in question, whichever happened earlier. The
proportional hazards assumption was tested through the
Schoenfeld residuals method, and there was no evidence of non-
proportionality for any covariates (all P> 0.11).
Models were fitted to predict each of our three outcome
variables in turn. For each model, robust standard errors were
applied to consider potential correlations between women with
same biological mother. Birth weight and gestational age showed
no evidence of nonlinearity as judged by including a quadratic
term (all P> 0.26), and were therefore entered as continuous
variables. All models were first adjusted for year of birth (before
1944, 1945–49, 1950–54, 1955–1959, 1960 or later) of the index
women to account for potential period effects. Birth weight was
additionally adjusted for gestational age. Index women’s parental
education, mother’s marital status, age and parity at birth were
further added in the adjusted models. Finally, index women’s
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number of live births, education and family disposable income in
year 2000 were included in the final models.
The proportion of missing data in study covariates was 0–5%.
This was imputed using multiple imputation (25 imputations)
under an assumption of missing at random. The imputation
model included all other covariates, event indicators and the
Nelson–Aalen estimator for cumulative hazard.25 All Cox models
were based on the imputed data.
Sensitivity analysis
To further assess the robustness of our results for women with
natural menopausal transition, we restricted our sample to 2993
women who had never had a hysterectomy or oophorectomy
before the start of the follow-up, defining these procedures using
the Swedish Classification of Operations and Major Procedures
(see Supplementary Table S1 for diagnostic codes).26 In the sen-
sitivity analyses, events of hysterectomy and oophorectomy were
additional censored from follow-up – this was not done in the
main analysis because the available operational codes are not
sufficiently detailed to identify procedures that mean a woman
has zero risk of disorders of natural menopause (e.g. bilateral
removal of ovaries and uterus).
All analyses were conducted using STATA version 14.2
(StataCorp). All statistical tests were two-sided.
Results
During the 8 years of follow-up, 218 women out of 3212 had a
diagnosed PD recorded in the patient registers (211 women in
outpatient register and 7 women in inpatient register). Among
them, 125 were diagnosed with menopausal and climacteric
states, 61 with perimenopausal bleeding and 58 with symptoms
linked to atrophic vaginitis or other unspecified PDs, and 26
women received more than one PD diagnosis.
As shown in Fig. 1, the incidence of menopausal and
climacteric states increased steadily from age 48 to 65. For peri-
menopausal bleeding, most cases occurred before age 55, while
other PDs were predominantly diagnosed after age 50. In general,
the incidence rate of being diagnosed with any PDs peaked
around age 50 (Supplementary Fig. S1).
Table 1 shows study subjects’ early-life and adult character-
istics, and corresponding PDs incidence rates. Rates of being
diagnosed with PDs were generally higher among women with
well-educated parents, and among women with a higher adult-
hood educational level themselves. Higher parity was associated
with a higher rate of other PDs. Moreover, women with more
number of live births during their adulthood had elevated rate of
bleeding-specific diagnoses. There were no substantial differences
in the incidence rate of PDs with other covariates. The above
results were very similar after adjustment for birth year of the
index woman (Supplementary Table S2).
Menopausal and climacteric states
Table 2 presents the estimated HRs for three subtypes of PDs per
unit increase in birth weight and gestational age. After minimally
adjusting for the woman’s age, birth year and gestational age,
increasing birth weight was linearly associated with higher rate
of menopausal and climacteric states (HR= 1.66 per 1 kg
increase, 95% CI= 1.14–2.41). This association was additionally
confirmed by categorizing birth weight into four groups: <3.0,
3.0–3.4, 3.5–3.9 and ≥4.0 kg (see Supplementary Table S3 for
alternative analyses with birth weight as a categorical variable).
The strength of the association with size at birth was very similar
when we instead used ponderal index as a relative measure of
body mass (weight for length). Specifically, the HR was 1.28
(95% CI= 1.07–1.54) for a 1 SD increase in birth weight, and 1.30
(95% CI= 1.10–1.54) for a 1 SD in ponderal index (Supplemen-
tary Table S4). The magnitude of the association of birth weight
with menopausal and climacteric states changed little after
adjusting for other early-life and adult characteristics (Table 2
and Supplementary Table S5). There was no evidence of an
association between gestational age and incidence of menopausal
and climacteric states (Table 2).
Perimenopausal bleeding disorders
For perimenopausal bleeding disorders, neither birth weight nor
gestational age showed associations with incidence rates (all
P> 0.27, Table 2). These results did not change appreciably after
adjustment for other early-life and adult socio-demographic
characteristics (Table 2 and Supplementary Table S5).
Other PDs
Birth weight was not associated with incidence of other PDs. Rate
of other disorders was, however, lower among women with longer
gestational age (minimally adjusted HR= 0.87, 95% CI= 0.79–
0.95 per completed gestational week, see Table 2). These results
changed little after additionally adjustment for other early-life and
adult characteristics (Table 2 and Supplementary Table S5).
Sensitivity analysis
All analyses were repeated with additional censoring for hyster-
ectomy or oophorectomy. The results were very similar to those
in the main analyses, except that the association of birth weight
with menopausal and climacteric states was somewhat stronger
(Supplementary Table S1).
Fig. 1. Nelson–Aalen estimates of cumulative incidence curves for types of study
outcomes: PDs and its three subtypes. The cumulative incidence was generated
separately for each study outcome among 3212 women. For the three subtypes of
PDs (i.e. menopausal and climacteric states, perimenopausal bleeding and other
disorders), we did not censor women who were diagnosed with a different subtype of
PDs. In total, 26 women received more than one subtype PDs diagnosis.
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Table 1. Descriptive statistics for the study covariates
No.a (%)
IR (95% CI)b
of PDs
IR (95% CI)b of menopausal and
climacteric states
IR (95% CI)b of perimenopausal
bleeding
IR (95% CI)b of
other PDs
Birth and early-life characteristic
Birth weight, kg
< 3.0 492 (15.3) 8.5 (6.0–12.2) 3.3 (1.9–5.9) 3.6 (2.1–6.2) 2.5 (1.3–4.8)
3.0–3.4 1198 (37.3) 10.3 (8.3–12.7) 4.9 (3.6–6.6) 3.4 (2.4–4.9) 3.0 (2.1–4.4)
3.5–3.9 1134 (35.3) 8.0 (6.3–10.2) 5.5 (4.1–7.4) 1.2 (0.6–2.2) 1.9 (1.2–3.1)
≥ 4.0 388 (12.1) 12.1 (8.7–17.0) 8.4 (5.6–12.6) 2.7 (1.4–5.5) 2.0 (0.9–4.5)
Gestational age, completed weeks
< 37 160 (5.2) 13.4 (8.1–22.2) 6.1 (2.9–12.7) 1.7 (0.4–6.8) 6.1 (2.9–12.7)
37–41 2480 (81.2) 9.3 (8.0–10.9) 5.3 (4.3–6.4) 2.7 (2.1–3.6) 2.4 (1.8–3.3)
≥ 42 416 (13.6) 7.6 (5.1–11.5) 4.6 (2.7–7.7) 1.9 (0.9–4.3) 1.0 (0.3–3.0)
Parental education
Elementary 1759 (54.8) 8.1 (6.7–9.8) 4.4 (3.4–5.7) 2.3 (1.6–3.3) 2.1 (1.4–3.0)
Shorter secondary 929 (28.9) 9.1 (7.1–11.7) 5.8 (4.3–7.9) 2.4 (1.5–3.9) 2.4 (1.5–3.9)
Longer secondary 352 (11.0) 14.9 (10.8–20.5) 7.4 (4.7–11.6) 3.5 (1.8–6.6) 4.2 (2.3–7.6)
Tertiary education 172 (5.4) 13.6 (8.5–21.9) 7.9 (4.2–14.7) 3.9 (1.6–9.3) 2.3 (0.7–7.1)
Mother’s marital status
Married 2845 (90.5) 9.6 (8.3–11.0) 5.4 (4.5–6.5) 2.4 (1.9–3.2) 2.5 (1.9–3.3)
Unmarried 300 (9.5) 7.8 (4.8–12.7) 3.3 (1.6–7.0) 3.8 (1.9–7.6) 1.4 (0.5–4.4)
Mother’s age, years
< 20 265 (8.3) 10.2 (6.4–16.1) 6.7 (3.8–11.7) 2.2 (0.8–5.8) 1.6 (0.5–5.0)
20–34 2704 (84.4) 9.5 (8.2–11.0) 5.3 (4.4–6.4) 2.6 (2.0–3.4) 2.5 (1.9–3.3)
≥ 35 236 (7.4) 7.8 (4.4–13.7) 3.8 (1.7–8.5) 2.5 (1.0–6.8) 1.9 (0.6–5.9)
Mother’s parity
1 1403 (44.6) 9.0 (7.3–11.1) 4.8 (3.6–6.4) 2.4 (1.6–3.6) 1.8 (1.2–2.9)
2 1023 (32.5) 9.2 (7.3–11.6) 5.6 (4.2–7.6) 2.2 (1.4–3.5) 2.8 (1.9–4.3)
3–9 719 (22.9) 10.5 (8.0–13.7) 5.5 (3.8–7.9) 3.4 (2.1–5.4) 3.0 (1.8–4.9)
Adult characteristics
Number of live births
0 388 (12.1) 5.7 (3.5–9.3) 5.0 (2.9–8.4) 0.7 (0.2–2.8) 2.1 (0.9–4.6)
1 466 (14.5) 9.4 (6.6–13.3) 5.0 (3.1–8.1) 1.5 (0.6–3.5) 3.2 (1.8–5.8)
2 1401 (43.6) 8.9 (7.3–11.0) 5.3 (4.1–6.9) 2.5 (1.7–3.7) 1.8 (1.2–2.8)
3–7 957 (29.8) 11.7 (9.4–14.6) 5.6 (4.1–7.6) 4.0 (2.7–5.7) 3.1 (2.0–4.7)
Own education c
Elementary 697 (21.7) 6.6 (4.7–9.3) 3.9 (2.5–6.1) 1.8 (0.9–3.5) 1.2 (0.5–2.7)
Shorter secondary 1260 (39.2) 9.2 (7.4–11.4) 5.7 (4.4–7.5) 2.3 (1.5–3.5) 2.2 (1.4–3.4)
Longer secondary 795 (24.8) 10.4 (8.1–13.4) 5.1 (3.5–7.3) 3.2 (2.0–5.9) 2.8 (1.8–4.5)
Tertiary education 459 (14.3) 12.6 (9.3–17.0) 6.7 (4.5–10.1) 3.2 (1.8–5.7) 4.0 (2.4–6.8)
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Discussion
Using prospective data on 3212 Swedish women, this study
investigated how birth weight and gestational age were associated
with incidence of PDs. Higher birth weight was associated with
increased incidence of menopausal and climacteric states such as
flushing, sleeplessness or headache, whereas shorter gestational
age was associated with increased incidence of other PDs (e.g.
atrophic vaginitis). Neither birth weight nor gestational age
showed associations with perimenopausal bleeding disorders. All
results were very similar after adjustment for other early-life and
adult socio-demographic characteristics.
Potential mechanisms
Compared to other important sources of health burden among
women, such as reproductive cancers27 and early menopause,28,29
the developmental origins of PDs have not been adequately
explored. Indeed, to our knowledge, this is the first study to
investigate the association between birth characteristics and PDs.
This limits direct comparisons of our research with other studies,
but we can discuss our findings in respect of possible mechanisms
based on previously identified adult risk factors.
Why higher birth weight is linked to the elevated risk of
menopausal and climacteric states is unknown. One possible
explanation is that high birth weight leads to adult overweight or
obesity, which in turn increases the risk of menopausal and cli-
macteric symptoms. The association between higher birth weight
and adult higher body mass index (BMI) or obesity is fairly well
established,12 although evidence regarding adult BMI and
menopausal symptoms is more mixed. These mixed findings may
reflect the effect modification by study subjects’ menopausal
status with respect to the association between adult BMI and
hormone/estrogen levels.30,31 One study has reported that over-
weight or obesity was associated with decreased risk of onset of
menopausal symptoms but only among postmenopausal women,
possibly reflecting the additional estrogen produced by their
greater quantities of adipose tissue (higher estrogen levels can
decrease the risk of menopause symptoms, in particular
vasomotor-related symptoms32).33 However, another study
focused specifically on perimenopausal women (aged between 45
and 54) found that high BMI was associated with decreased
estrogen levels and higher risk of menopausal symptoms.30 This
second study further reported a longer duration of perimeno-
pause among obese women, suggesting that the decreased peri-
menopausal estrogen levels might reflect earlier onset of ovarian
insufficiency (one phenomenon of early menopause).30 This
interpretation is supported by two epidemiological studies in
which the association between higher birth weight and earlier
menopause were found18,19 – although the degree of mediation
through adult BMI on such association is unclear.
In summary, therefore, one possible explanation for the
association between higher birth weight and the elevated risk of
diagnosed menopausal states is that high birth weight predicts
high adult BMI in the perimenopausal period. This is an area that
requires further research, including consideration of potential
upstream determinants (and potential targets for intervention)
such as maternal obesity or diabetes. Regardless of the mechanism,
our findings provide some supports for the developmental
origins hypothesis that the perinatal period is a sensitive period
for adult health, with exposure to adverse intrauterine environ-
ments potentially causing long-term health harms.15
The lack of associations between birth characteristics and peri-
menopausal bleeding is arguably not surprising, given that abnormal
bleeding is a marker for gynecological lesions or malignancies, which
were not associated with birth weight in a recent meta-analysis.27
The identified evidence of the association between shorter gestational
age and increased risk of other PDs (e.g. vaginal or endometrial
atrophy) could be the result of inadequate development of ovarian
function and reproductive organs during prenatal period.
Strengths
The primary strength of the current research is its longitudinal
design. This is uncommon in the field: most previous studies
examining risk factors for menopause-related symptoms instead
use cross-sectional data,21,34 which limits their ability to explore
potential long-term predictors such as birth characteristics. In this
study, this association can be studied for the first time by linking
archived birth records to national patient register. The prospective
collection of early-life and premenopausal adult characteristics and
the use of register-based diagnoses avoid potential problems of
recall bias and differential misclassification of the outcomes.
Limitations and future directions
Nevertheless, our register-based design also arose some limitations
of this study. Our outcomes were PDs diagnoses, as extracted from
inpatient and outpatient registers. It is likely that only severe
symptoms were captured in this study, because most women may
not consider menopausal symptoms as disorders unless it seriously
Table 1. (Continued )
No.a (%)
IR (95% CI)b
of PDs
IR (95% CI)b of menopausal and
climacteric states
IR (95% CI)b of perimenopausal
bleeding
IR (95% CI)b of
other PDs
Family disposable income,d mean
(SD), fourthsc
1st (highest), 400 + 571 (532) 9.7 (7.5–12.6) 6.1 (4.4–8.4) 2.4 (1.5–4.1) 1.8 (1.0–3.2)
2nd, 294–399 342 (30) 8.3 (6.3–11.0) 4.0 (2.7–5.9) 3.0 (1.9–4.7) 2.3 (1.4–3.9)
3rd, 180–293 240 (35) 10.9 (8.5–14.0) 5.6 (3.9–7.9) 3.1 (2.0–4.9) 3.6 (2.3–5.5)
4th (lowest), 0–179 131 (32) 8.9 (6.7–11.7) 5.6 (4.0–7.9) 1.7 (0.9–3.2) 2.1 (1.2–3.6)
CI, confidence interval; IR, incidence rate; PDs, perimenopausal disorders.
aNumbers add up to <3212 for some covariates due to missing data.
bPer 1000 person-years.
cAt year 2000.
dPresented in thousands Swedish Krona.
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affects their general health. It can be assumed that we missed a
considerable number of less severe cases among women who did
not seek health care and who were treated in the primary care
system. Differences in health-seeking behaviors might also explain
why higher education was found to be associated with a higher risk
of PDs in the present study, whereas previous survey-based
research in United States reported the opposite association.20 As
such, further research would be valuable to establish whether our
findings can be generalized to all menopausal disorders.
Another limitation is that this study lacked the data to study
surgical menopause, while additional censoring on hysterectomy
and oophorectomy did not change the direction or magnitudes of
the main results. Relatedly, although we categorized PDs in as
much detail as the ICD allows, our outcomes were relatively broad
in comparison to previous studies that have looked at symptom
profiles (i.e. psychological, vasomotor, somatic and sexual dis-
comfort profiles).5 Thus, future studies with detailed outcome data
would be valuable, to explore the early-life predictors of different
aspects of PDs. A third limitation is that the lack of investigation
on potential mediating pathways or accumulation of risk across the
life course may underlie the observed associations (e.g. adult BMI
or hormonal factors) to identify strategies for earlier interventions.
Thus, further research into the mechanisms of the developmental
origins of PDs is warranted. Additionally, the absence of infor-
mation regarding women’s age at menopause limits our ability to
detect the differences in timing of onset of PDs by birth char-
acteristics. Finally, this study may not consider all potential
maternal/family-level confounding factors, thus any causal inter-
pretation needs to be made with caution. Although our sample size
was not large enough to permit sibling analyses, such analyses
could strengthen the case for causality would be one useful method
to apply to larger data sets. Opportunities for doing this in Sweden
will arise within the next 10 years, once women included in the
Medical Birth Register (started in 1973) reach menopausal age.
Conclusion
This observational study provides, for the first time, suggestive
evidence as to the developmental origins of PDs. We found that
higher birth weight was associated with increased incidence of
menopausal and climacteric states, and shorter gestational age
was associated with increased incidence of other PDs such as
atrophic vaginitis. No associations with birth characteristics were
detected for perimenopausal bleeding. Future research should
seek to replicate these findings in other populations in different
contexts. If replicated, investigating the underlying causal
mechanisms may shed further light on the etiology of this
important class of disorders, and potentially identify targets for
intervention.
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